{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T23:16:31Z","timestamp":1775862991645,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Otolaryngologic Clinics of North America"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.otc.2023.07.012","type":"journal-article","created":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T19:20:18Z","timestamp":1692991218000},"page":"111-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Surgery for Normocalcemic Hyperparathyroidism"],"prefix":"10.1016","volume":"57","author":[{"given":"Pallavi","family":"Kulkarni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Goldenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"jun02 15","key":"10.1016\/j.otc.2023.07.012_bib1","doi-asserted-by":"crossref","first-page":"h2723","DOI":"10.1136\/bmj.h2723","article-title":"The diagnosis and management of hypercalcaemia","volume":"350","author":"Minisola","year":"2015","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.otc.2023.07.012_bib2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrendo.2017.104","article-title":"Primary hyperparathyroidism","volume":"14","author":"Walker","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.otc.2023.07.012_bib3","unstructured":"Rajkumar V, Levine SN. Normocalcemic Hyperparathyroidism. Updated 2022 Sep 3. In: StatPearls Internet. Treasure Island (FL): StatPearls Publishing; 2023-. Available from: https:\/\/www-ncbi-nlm-nih-gov.ezaccess.libraries.psu.edu\/books\/NBK555967\/."},{"issue":"11","key":"10.1016\/j.otc.2023.07.012_bib4","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/jbmr.4677","article-title":"Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop","volume":"37","author":"Bilezikian","year":"2022","journal-title":"J\u00a0Bone Miner Res"},{"issue":"3","key":"10.1016\/j.otc.2023.07.012_bib5","doi-asserted-by":"crossref","first-page":"294","DOI":"10.4158\/EP15704.OR","article-title":"Primary hyperparathyroidism, with a focus on management of the normocalcemic form: to treat or not to treat?","volume":"22","author":"\u0160iprov\u00e1","year":"2016","journal-title":"Endocr Pract"},{"key":"10.1016\/j.otc.2023.07.012_bib6","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1210\/jc.2006-2802","article-title":"Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype","volume":"92","author":"Lowe","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.otc.2023.07.012_bib7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/archinte.1980.00330140063019","article-title":"Hyperparathyroidism following head and neck irradiation","volume":"140","author":"Rao","year":"1980","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.otc.2023.07.012_bib8","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3803\/EnM.2021.1061","article-title":"Normocalcemic primary hyperparathyroidism: need for a standardized clinical approach","volume":"36","author":"Zavatta","year":"2021","journal-title":"Endocrinology and Metabolism"},{"issue":"Issue 10","key":"10.1016\/j.otc.2023.07.012_bib9","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1210\/jc.2014-1414","article-title":"Diagnosis of Asymptomatic Primary Hyperparathyroidism: Proceedings of the Fourth International Workshop","volume":"99","author":"Eastell","year":"2014","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"Issue 4","key":"10.1016\/j.otc.2023.07.012_bib10","doi-asserted-by":"crossref","first-page":"e1171","DOI":"10.1210\/clinem\/dgaa084","article-title":"Normocalcemic Hyperparathyroidism: Study of its Prevalence and Natural History","volume":"105","author":"Schini","year":"2020","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"2","key":"10.1016\/j.otc.2023.07.012_bib11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s12020-021-02845-4","article-title":"A\u00a0practical approach to normocalcemic primary hyperparathyroidism","volume":"74","author":"Mu\u00f1oz de Nova","year":"2021","journal-title":"Endocrine"},{"issue":"6","key":"10.1016\/j.otc.2023.07.012_bib12","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.beem.2018.09.009","article-title":"Management of normocalcemic primary hyperparathyroidism","volume":"32","author":"Cusano","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.otc.2023.07.012_bib13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/imj.15502","article-title":"Normocalcaemic primary hyperparathyroidism: is nephrolithiasis more common than osteoporosis?","volume":"53","author":"Wu","year":"2023","journal-title":"Intern Med J"},{"issue":"1","key":"10.1016\/j.otc.2023.07.012_bib14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.surg.2022.05.042","article-title":"Phenotypes of primary hyperparathyroidism: Does parathyroidectomy improve clinical outcomes for all?","volume":"173","author":"Armstrong","year":"2023","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.otc.2023.07.012_bib15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4081\/aiua.2015.1.66","article-title":"Use of cinacalcet in nephrolithiasis associated with normocalcemic or hypercalcemic primary hyperparathyroidism: results of a prospective randomized pilot study","volume":"87","author":"Brardi","year":"2015","journal-title":"Arch Ital Urol Androl"},{"issue":"4","key":"10.1016\/j.otc.2023.07.012_bib16","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s00198-014-3000-2","article-title":"Effects of alendronate and vitamin D in patients with normocalcemic primary hyperparathyroidism","volume":"26","author":"Cesareo","year":"2015","journal-title":"Osteoporos Int"},{"issue":"13","key":"10.1016\/j.otc.2023.07.012_bib17","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.3346\/jkms.2022.37.e99","article-title":"Comparisons Between Normocalcemic Primary Hyperparathyroidism and Typical Primary Hyperparathyroidism","volume":"37","author":"Choi","year":"2022","journal-title":"J\u00a0Korean Med Sci"},{"key":"10.1016\/j.otc.2023.07.012_bib18","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.surg.2019.06.043","article-title":"Normocalcemic hyperparathyroidism: a Collaborative Endocrine Surgery Quality Improvement Program analysis","volume":"167","author":"Pandian","year":"2020","journal-title":"Surgery"},{"issue":"10","key":"10.1016\/j.otc.2023.07.012_bib19","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop","volume":"99","author":"Bilezikian","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.otc.2023.07.012_bib20","first-page":"100317","article-title":"Symptomatic versus asymptomatic primary hyperparathyroidism: A systematic review and meta-analysis","volume":"32","author":"Kulkarni","year":"2023","journal-title":"J\u00a0Clin Transl Endocrinol"},{"issue":"4","key":"10.1016\/j.otc.2023.07.012_bib21","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.surg.2021.08.047","article-title":"What happens to the bone structure after normocalcemic primary hyperparathyroidism surgery?","volume":"171","author":"Osorio-Silla","year":"2022","journal-title":"Surgery"},{"issue":"8","key":"10.1016\/j.otc.2023.07.012_bib22","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1210\/jc.2013-1518","article-title":"Bone mineral density evolution after successful parathyroidectomy in patients with normocalcemic primary hyperparathyroidism","volume":"98","author":"Koumakis","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.otc.2023.07.012_bib23","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12872-019-1093-4","article-title":"Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism","volume":"19","author":"Beysel","year":"2019","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.otc.2023.07.012_bib24","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s00268-019-05157-x","article-title":"Biochemical profile affects IOPTH kinetics and cure rate in primary hyperparathyroidism","volume":"44","author":"Graves","year":"2020","journal-title":"World J Surg"},{"issue":"10","key":"10.1016\/j.otc.2023.07.012_bib25","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","article-title":"The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism","volume":"151","author":"Wilhelm","year":"2016","journal-title":"JAMA Surg"},{"key":"10.1016\/j.otc.2023.07.012_bib26","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1245\/s10434-018-6998-0","article-title":"Biochemical and Skeletal Outcomes of Parathyroidectomy for Normocalcemic (Incipient) Primary Hyperparathyroidism","volume":"26","author":"Sho","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.otc.2023.07.012_bib27","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00268-012-1438-y","article-title":"Surgical management of normocalcemic primary hyperparathyroidism","volume":"6","author":"Wade","year":"2012","journal-title":"World J Surg"},{"issue":"4","key":"10.1016\/j.otc.2023.07.012_bib28","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/1754-9485.12728","article-title":"Better performance of four-dimension computed tomography as a localization procedure in normocalcemic primary hyperparathyroidism","volume":"62","author":"Cunha-Bezerra","year":"2018","journal-title":"J\u00a0Med Imaging Radiat Oncol"}],"container-title":["Otolaryngologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0030666523001329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0030666523001329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T22:50:05Z","timestamp":1700002205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0030666523001329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0030666523001329"],"URL":"https:\/\/doi.org\/10.1016\/j.otc.2023.07.012","relation":{},"ISSN":["0030-6665"],"issn-type":[{"value":"0030-6665","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surgery for Normocalcemic Hyperparathyroidism","name":"articletitle","label":"Article Title"},{"value":"Otolaryngologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.otc.2023.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}